뇌손상 환자에서 입벌림 장애에 대한 보툴리눔 독소 A의 효과-증례보고-
Effect of Botulinum Toxin A on Trismus after Traumatic Brain Injury A case report
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We report a case of severe trismus following traumatic brain injury (TBI), which was treated successfully with botulinum toxin A. Its effect evidenced long-term resolution, for over one year. A 36 year-old man with a multifocal intracranial hemorrhage was admitted for quadriplegia with dysphagia and trismus. During ten months, a nasogastric tube was placed for feeding after TBI, and at that time his upper- to-lower interincisal distance was only 1.2 cm upon voluntary mouth opening. Botulinum toxin A 450 U (DysportⓇ) was injected into both masseter, medial pterygoid and left temporalis muscles under electromyographic guidance. The interincisal distance began to improve one week after injection. He successfully underwent percutaneous endoscopic gastrostomy, dysphagia rehabilitation therapy, and dental prosthesis. More than one month after injection, oral feeding proved possible. After 1 year his interincisal distance was maintained at 2.9 cm.
Abstract
We report a case of severe trismus following traumatic brain injury (TBI), which was treated successfully with botulinum toxin A. Its effect evidenced long-term resolution, for over one year. A 36 year-old man with a multifocal intracranial hemorrhage was admitted for quadriplegia with dysphagia and trismus. During ten months, a nasogastric tube was placed for feeding after TBI, and at that time his upper- to-lower interincisal distance was only 1.2 cm upon voluntary mouth opening. Botulinum toxin A 450 U (DysportⓇ) was injected into both masseter, medial pterygoid and left temporalis muscles under electromyographic guidance. The interincisal distance began to improve one week after injection. He successfully underwent percutaneous endoscopic gastrostomy, dysphagia rehabilitation therapy, and dental prosthesis. More than one month after injection, oral feeding proved possible. After 1 year his interincisal distance was maintained at 2.9 cm.
참고문헌 (10)
- Tveterås K, "The aetiology and pathogenesis of trismus", Clin Otolaryngol Allied Sci, 11, pp.383~387 (1986)
- Daelen B, "Treatment of recurrent dislocation of the temporomandibular joint with type A botulinum toxin", Int J Oral Maxillofac Surg, 26, pp.458~460 (1997)
- Freund B, "Botulinum toxin: new treatment for temporomandibular disorders", Br J Oral Maxillofac Surg, 38, pp.466~471 (2000)
- Pidcock FS, "Treatment of severe post-traumatic bruxism with botulinum toxin-A: case report", J Oral Maxillofac Surg, 60, pp.115~117 (2002)
- Kadyan V, "Severe trismus as a complication of cerebrovascular accident: a case report", Arch Phys Med Rehabil, 86, pp.594~595 (2005)
- Spillane KS, "Stroke-induced trismus in a pediatric patient: long-term resolution with botulinum toxin A", Am J Phys Med Rehabil, 82, pp.485~488 (2003)
- Belafsky PC, "The accuracy of the modified Evan's blue dye test in predicting aspiration", Laryngoscope, 113, pp.1969~1972 (2003)
- Pierson SH, "Botulinum toxin A in the treatment of spasticity: functional implications and patient selection", Arch Phys Med Rehabil, 77, pp.717~721 (1996)
- Kim DY, "Botulinum toxin type A for poststroke cricopharyngeal muscle dysfunction", Arch Phys Med Rehabil, 87, pp.1346~1351 (2006)
- Restivo DA, "Trismus after stroke", TBI: botulinum toxin benefit and use pre-PEG placement, 2005, pp.64, 2152~2153